NCT04428632Approved For Marketing不适用
Expanded Access Program With Oral Berotralstat for the Prevention of Attacks in Patients With Hereditary Angioedema
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- Approved For Marketing
研究概览
简要总结
This expanded access program will provide access to berotralstat for eligible participants with hereditary angioedema in the U.S.
详细描述
Physicians may request access to berotralstat for eligible participants with unmet medical need
Physicians can send email inquiries to access.us@inceptua.com or call 1-888-225-8677
Patients who may be interested should contact their physician about participation
Berotralstat (BCX7353) will be available through this expanded access program until it is commercially available
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
No Longer Available
不适用
Expanded Access to Bimatoprost (Durysta)Open-angle GlaucomaNCT05338606AbbVie
Unknown
3 期
Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat StudiesHAEHereditary AngioedemaNCT04933721BioCryst Pharmaceuticals139
No Longer Available
不适用
Expanded Access to FosigotifatorVanishing White MatterCree LeukoencephalopathyNCT06594016AbbVie
Available
不适用
Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 DeficiencyMonocarboxylate Transporter 8 DeficiencyAllan-Herndon-Dudley SyndromeNCT05911399Rare Thyroid Therapeutics International AB
Approved For Marketing
不适用
Donidalorsen Expanded Access Program for Patients With Hereditary AngioedemaHereditary AngioedemaNCT06415448Ionis Pharmaceuticals, Inc.